Covid-19

A Phase 2/3 Study to Evaluate Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273 to Healthy Children

Pneumococcal Vaccine

A Study of the Safety and Immunogenicity of a 21-valent Pneumococcal Conjugate Vaccine in Healthy children

Molluscum Contagiosum

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study for Children Ages 6 Months and Older with 3-70 Lesions

Where Personalized Approach Meets Therapeutic Expertise

Let's Talk About Your Next Trial

Name
Scroll to Top